Cardiopulmonary Exercise Test in Peripheral Arterial Disease
Launched by LIVERPOOL UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Jan 13, 2016
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
Patients scheduled to undergo surgery or angioplasty of the iliofemoral segment for intermittent claudication will be screened for inclusion. Consenting patients will undergo ABI measurements and CPET before treatment and four weeks after treatment. Study measures will be performed in the respiratory physiology laboratory at University Hospital Aintree. Demographic and medical details will be recorded including gender, age, smoking history and pack years, medical history and treatment and BMI. A record will be made of patuients' latest full blood count which will be routinely available in a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written informed consent, ability to perform a CPET on a cycle ergometer, intermittent claudication as presenting complaint, age ≥18, iliofemoral arterial disease
- Exclusion Criteria:
- • Critical limb ischaemia, unwillingness to consent, previous amputation or other inability to perform CPET on a cycle ergometer, age \<18, absence of iliofemoral arterial disease, any standard CPET exclusion based on American Thoracic Society/European Respiratory Society Guidelines, including severe arthritis or lower limb abnormality precluding exercise testing, severe hypertension at rest, unstable angina or acute coronary syndrome within the previous 6 weeks, terminal illness/advanced cancer or major psychiatric illness, including dementia, which precludes consent
About Liverpool University Hospitals Nhs Foundation Trust
Liverpool University Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to providing high-quality patient care, advancing medical research, and fostering education in the health sciences. With a strong commitment to innovation and excellence, the Trust actively participates in clinical trials aimed at improving treatment outcomes and enhancing healthcare delivery. By collaborating with academic institutions and industry partners, Liverpool University Hospitals NHS Foundation Trust strives to bridge the gap between research and clinical practice, ensuring that cutting-edge therapies and interventions are accessible to patients in the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liverpool, , United Kingdom
Patients applied
Trial Officials
Francesco Torella
Principal Investigator
Aintree University Hospital Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials